Episode notes
This week, we’re talking to some of the companies that attended the American Association for Cancer Research (AACR) annual meeting in Chicago.
We have interviews with Microbiotica, 1Cell.Ai, and Tessellate Bio.
Interview times:
01:55 Tessellate Bio
17:02 1Cell.Ai (formerlyOneCell Diagnostics)
44:04 Microbiotica
Microbiotica
Mat Robinson, SVP Research at Microbiotica, is one of our guests.
Microbiotica presented new data at AACR about the microbiome and the mechanism of action of MB097, a clinical-stage drug candidate being evaluated in combination with KEYTRUDA (pembrolizumab) in patients with advanced melanoma.
MB097 comprises nine different spec ...
Keywords
biotechbiotechnologycanceroncologyMicrobioticamicrobiomeTessellate BioOneCell Diagnostics